Lirimilast [CAS 329306-27-6]
Partner: MedChemexpress LLC
| CAS No: | 329306-27-6 |
| Applications: | COVID-19-immunoregulation |
| MW: | 443.26 |
| Formula: | C17H12Cl2N2O6S |
| SMILES: | O=C(N)NC1=C(C(C2=CC=C(Cl)C=C2Cl)=O)OC3=CC(OS(=O)(C)=O)=CC=C13 |
| Purity: | 98.69 |
| Description: | Lirimilast (BAY 19-8004) is a potent, selective and orally active phosphodiesterase-4 (PDE4) inhibitor with an IC50 value of 49 nM. Lirimilast can be used for the treatment of asthma or chronic obstructive pulmonary disease (COPD). Lirimilast has potently anti-inflammatory properties[1][2]. |
| Shipping Conditions: | Ship on cold packs |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
